Brady Corporation — Form 10-Q Summary
Business context and period. Brady manufactures identification solutions and workplace safety products. This filing covers the first quarter of fiscal 2018, the three months ended October 31, 2017, compared with the three months ended October 31, 2016. Amounts below are in U.S. dollars; financial statement figures are in millions unless stated otherwise.
Financial performance and condition
| Metric | Q1 FY2018 | Q1 FY2017 | Change / context |
|---|---|---|---|
| Net sales | $290.2 | $280.2 | Up 3.6%; organic growth 1.7%, currency benefit 1.9% |
| Gross profit / margin | $146.1 / 50.3% | $140.4 / 50.1% | Margin up 0.2 percentage points |
| Operating income / margin | $35.4 / 12.2% | $33.2 / 11.9% | Higher year over year |
| Net earnings | $25.8 | $22.6 | Up 14.6% |
| Diluted EPS, Class A | $0.49 | $0.44 | Up $0.05 |
| Operating cash flow | $34.7 | $34.0 | Up $0.7 |
| Capital expenditures | $3.8 | $4.0 | Comparable |
Research and development expense rose to $10.5 million from $9.1 million, primarily reflecting increased IDS product-development investment. SG&A increased to $100.1 million from $98.0 million, but declined as a share of sales to 34.5% from 35.0%. The effective tax rate was 25.7%, versus 27.2%, helped by foreign tax credits generated from a cash repatriation to the U.S. Interest expense fell to $0.9 million from $1.7 million as debt declined.
Cash and cash equivalents were $142.2 million at October 31, 2017, up $8.3 million from July 31, 2017. Financing activities used $21.7 million, including dividends and net credit-facility repayments. Long-term obligations were $93.8 million and current notes payable were $0.7 million. The revolving credit facility had $41.5 million outstanding, with $254.4 million available; availability could increase to $404.4 million subject to conditions. Brady was in compliance with its debt covenants: debt-to-EBITDA was 0.6x against a 3.25x maximum, and interest coverage was 37.1x against a 3.0x minimum. The company said operating cash flow and borrowing capacity should fund anticipated needs for the next 12 months. 91.3% of cash was held outside the U.S.
Material changes and segment results
- Identification Solutions (IDS): Sales rose 4.2% to $209.7 million, including 2.9% organic growth and a 1.3% currency benefit. Segment profit increased 8.4% to $35.8 million; profit margin rose to 17.1% from 16.4%. Growth in Product ID and Wire ID, particularly in Europe and Asia, was partly offset by Healthcare ID declines and pricing pressure in the U.S.
- Workplace Safety (WPS): Sales rose 1.9% to $80.4 million, entirely supported by a 3.3% currency benefit offsetting a 1.4% organic decline. Segment profit was $6.4 million versus $6.5 million, and margin declined to 8.0% from 8.2%. Catalog weakness and pricing pressure in the Americas were partly offset by digital growth and lower selling expense.
Management attributed improved gross margin to manufacturing efficiencies and lower excess-inventory and scrap charges. Foreign exchange also supported reported sales and operating income. Other comprehensive loss was $7.4 million, primarily reflecting currency translation, which reduced stockholders’ investment.
Outlook, risks and notable items
The filing provides no quantified earnings or sales guidance. Management’s fiscal 2018 priorities include innovation, operational efficiency, digital expansion, and focused sales and marketing. It expects cash flow and available borrowing capacity to cover anticipated requirements, while noting that repatriating foreign cash could create incremental taxes. A quarterly dividend of $0.2075 per share was declared on November 14, 2017, payable January 31, 2018.
Key risks discussed include weaker product demand, competition, execution of growth and efficiency initiatives, customer retention, cybersecurity, pricing pressure, foreign-exchange movements, tax changes, litigation and product liability, acquisition integration, and potential impairment of substantial goodwill and intangible assets. No goodwill impairment was recorded in the quarter; the filing reports $328.0 million of accumulated goodwill impairment losses. Brady reported no material off-balance-sheet arrangements and no material change in previously disclosed market-risk information. Disclosure controls were judged effective, with no material change in internal control over financial reporting.
The company was evaluating new accounting standards, including revenue recognition (planned adoption August 1, 2018, with modified retrospective application anticipated), leases, and hedge accounting. The filing does not quantify the expected financial impact of these standards.
Important facts for investors to verify
- Whether IDS organic growth continues and WPS catalog declines and Americas pricing pressure improve.
- How much reported growth and earnings continue to depend on favorable currency movements and the lower tax rate.
- Cash location and potential tax cost of repatriating foreign-held funds, alongside credit availability and covenant headroom.
- The eventual effect of revenue-recognition and lease-accounting adoption, and any future goodwill or intangible-asset impairment.